Technical Analysis for TARS - Tarsus Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Earnings Movers | Other | 0.00% | |
Gapped Up | Strength | 0.00% | |
Calm After Storm | Range Contraction | 1.34% | |
Upper Bollinger Band Touch | Strength | 1.34% | |
Crossed Above 20 DMA | Bullish | 4.05% | |
Crossed Above 50 DMA | Bullish | 4.05% | |
New Uptrend | Bullish | 4.05% | |
180 Bullish Setup | Bullish Swing Setup | 4.05% |
Alert | Time |
---|---|
Possible NR7 | about 15 hours ago |
Rose Above Previous Day's High | about 19 hours ago |
Gap Up Partially Closed | about 19 hours ago |
Gapped Up (Partial) | about 19 hours ago |
Up 3% | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Irvine, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Ophthalmic Malaria Rosacea Blepharitis Meibomian Gland
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Ophthalmic Malaria Rosacea Blepharitis Meibomian Gland
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 42.5 |
52 Week Low | 12.66 |
Average Volume | 588,244 |
200-Day Moving Average | 23.62 |
50-Day Moving Average | 34.36 |
20-Day Moving Average | 34.71 |
10-Day Moving Average | 36.98 |
Average True Range | 2.40 |
RSI (14) | 60.78 |
ADX | 32.49 |
+DI | 32.19 |
-DI | 7.43 |
Chandelier Exit (Long, 3 ATRs) | 35.31 |
Chandelier Exit (Short, 3 ATRs) | 37.41 |
Upper Bollinger Bands | 39.75 |
Lower Bollinger Band | 29.66 |
Percent B (%b) | 0.88 |
BandWidth | 29.07 |
MACD Line | 1.08 |
MACD Signal Line | 0.64 |
MACD Histogram | 0.4408 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.60 | ||||
Resistance 3 (R3) | 40.75 | 40.19 | 40.25 | ||
Resistance 2 (R2) | 40.19 | 39.66 | 40.12 | 40.13 | |
Resistance 1 (R1) | 39.35 | 39.33 | 39.07 | 39.20 | 40.02 |
Pivot Point | 38.79 | 38.79 | 38.66 | 38.72 | 38.79 |
Support 1 (S1) | 37.95 | 38.26 | 37.67 | 37.80 | 36.98 |
Support 2 (S2) | 37.39 | 37.93 | 37.32 | 36.87 | |
Support 3 (S3) | 36.55 | 37.39 | 36.75 | ||
Support 4 (S4) | 36.40 |